These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6603223)

  • 1. Circulating C1q binding immune complexes in relatives of patients with systemic lupus erythematosus.
    Elkon KB; Walport MJ; Rynes RI; Black CM; Batchelor JR; Hughes GR
    Arthritis Rheum; 1983 Jul; 26(7):921-4. PubMed ID: 6603223
    [No Abstract]   [Full Text] [Related]  

  • 2. C1q binding and C1q deviation assays using enzyme labelled C1q.
    Smith GW; Myles MJ; Simpson IJ
    J Immunol Methods; 1984 Feb; 67(1):167-72. PubMed ID: 6366065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid phase C1q microassay for the rapid detection of circulating immune complexes.
    Orozco A; Contreras CE; Sánchez P; Meilijson O; Bianco NE
    J Immunol Methods; 1983 Apr; 59(2):237-43. PubMed ID: 6341470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IgG-bound DNA and C1q-binding materials in iupus nephritis].
    Koyama A; Narita M; Lshida H; Inage H; Sano M; Tojo S
    Nihon Jinzo Gakkai Shi; 1982 Mar; 24(3):267-74. PubMed ID: 6981719
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of the C1q binding assay in the analysis of immune complexes: personal experiences with its clinical use and future prospectives].
    Corvetta A; Spaeth PJ; Panico F; Ghirelli PA; Orecchioni F; Danieli G
    G Clin Med; 1983; 64(9-10):337-48. PubMed ID: 6198235
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    Clin Immunol Immunopathol; 1984 Jan; 30(1):104-16. PubMed ID: 6421520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of circulating immune complexes in lupus nephritis by solid phase C1q and conglutinin binding assays.
    Yoshida H; Muso E; Inoue S; Furukawa F; Sekita K; Kawai C; Hamashima Y
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):293-300. PubMed ID: 6611433
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serial studies of serum immune complexes and complements in patients with glomerulonephritis].
    Nakayama S; Koide H; Ohno J
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):163-9. PubMed ID: 6611432
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of circulating immune complexes by a C1q-microplate ELISA system.
    Singh VK; Tingle AJ
    J Immunol Methods; 1982; 50(1):109-14. PubMed ID: 6177790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
    Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
    J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single-stranded DNA on circulating immune complexes in SLE sera detected by C1q solid-phase assay.
    Furukawa F; Sekita K; Muso E; Imamura S; Hamashima Y
    Arch Dermatol Res; 1985; 277(1):71-4. PubMed ID: 3871602
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of immune complexes in systemic lupus erythematosus with the C1q solid phase assay: correlation with nDNA antibodies and hypocomplementemia.
    Agnello V; Mitamura T
    Clin Immunol Immunopathol; 1987 Mar; 42(3):338-43. PubMed ID: 3493866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
    Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
    Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration.
    Lin RY; Racis SP
    Int Arch Allergy Appl Immunol; 1986; 79(3):286-90. PubMed ID: 2419257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes in SLE.
    Inman RD
    Clin Rheum Dis; 1982 Apr; 8(1):49-62. PubMed ID: 6214365
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating immune complexes in patients with glomerulonephritis and in renal transplant patients.
    Sølling J
    Scand J Urol Nephrol Suppl; 1985; 97():1-46. PubMed ID: 3915401
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical utility of assays for circulating immune complexes.
    Endo L; Corman LC; Panush RS
    Med Clin North Am; 1985 Jul; 69(4):623-36. PubMed ID: 3903373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for detection of low molecular weight DNA--anti-DNA complexes in systemic lupus erythematosus.
    Agnello V; Mitamura T
    Arthritis Rheum; 1982 Jul; 25(7):788-92. PubMed ID: 7049182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.